Close Menu

gel electrophoresis

Coastal Genomics owns the Ranger gel electrophoresis technology to collect specific DNA target sizes, with applications in noninvasive prenatal testing and oncology.

The team's method utilizes two plasmids that produce DNA fragments from 50 to 1,000 bp, and are available through the nonprofit organization AddGene.

The partners plan to commercialize the system called Gly-Q for applications such as biotherapeutic cell line development. 

While the technology is not meant to replace mass spectrometry-based methods of PTM analysis, its developers said that it does offer a quicker, easier, and cheaper method to visualize modified proteins. Further, they added, the technology may eventually be used to develop diagnostic tools for diseases such as Alzheimer's, diabetes, and cancer.

Analyze This Proteome

Premium

Two main technologies vie for the top protein analysis method spot. GT looks at the latest and greatest approaches for studying proteins.

Funding Update for Mar 5, 2009

Premium

Recent NSF Awards in Proteomics and Protein Research Mar 5, 2009

The World of DIY Bio

Premium

Cloning in the kitchen? Sandra Porter checks out the DIYbio group and finds some great principles and some not-so-great biology.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.